Johnson & Johnson (JNJ) Stock: Surges as J&J Offers $5.5 Billion Talc Settlement to End Cancer Lawsuits
TLDR JNJ offers $5.5B settlement covering about 76,000 talc cancer claims. JNJ stock rises after proposed deal targets long-running talc litigation. Settlement needs 95% claimant approval bef







